Evidence map›Paper›PMID 39822500›Full record

ArticleAmerican journal of translational research2024

Value of CT diagnostic techniques based on imaging post-processing systems in the early diagnosis and treatment of lung cancer.

Wanling Li, Xuelan Zheng, Jishui Huang

Abstract read
In one paragraph

Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wanling LiComputed Magnetic Resonance Imaging Tomography, The Second Affiliated Hospital of Fujian Medical University Quanzhou 362000, Fujian, China.
Xuelan ZhengIntensive Care Unit, The Second Affiliated Hospital of Fujian Medical University Quanzhou 362000, Fujian, China.
Jishui HuangRespiratory and Critical Care Medicine, Nan'an City Hospital Quanzhou 362399, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the application value of CT diagnostic technology based on the Shukun Imaging Post-Processing System for early screening and diagnosis of lung cancer.

methodsA total of 35 patients diagnosed with lung cancer postoperatively and 53 patients with benign nodules were included in this retrospective study, all of whom were treated in the Department of Thoracic and Cardiovascular Surgery of the Second Affiliated Hospital of Fujian Medical University from January 2020 to December 2023. All patients underwent chest spiral CT examinations. Original thin-slice axial CT images were processed using Shukun software for three-dimensional reconstruction of the lesions, surrounding lung tissue, and trachea. The diagnoses and malignant risk indicators of pulmonary nodules were established based on the final imaging results.

resultsStatistical analysis showed that the sensitivity of Shukun processing technology in diagnosing early-stage lung cancer was 82.86%, with a specificity of 88.46%, when compared to postoperative pathological analysis. Univariate logistic regression analysis indicated that features such as burr sign, lobulation sign, pleural traction sign, vascular convergence sign, vacuole sign, and nodule size derived from Shukun processing had significant predictive value for malignant nodules (P<0.05).

conclusionShukun processing technology can effectively reconstruct ordinary CT tomographic images into three-dimensional representations, enhancing the visualization of spatial relationships between the tumor and adjacent anatomical structures, including trachea, pleura, bronchi, and blood vessels. It has high clinical diagnostic value for the early diagnosis of malignant pulmonary nodules.

Indexed as

chest CTdiagnostic efficacylung cancerPulmonary noduleShukun imaging post-processing system

Identifiers

PMID39822500
PMCPMC11733320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.